List of Devices Companies in Germany - 21

AATec Medical GmbH is a biotech company developing a product platform based on recombinant alpha-1 antitrypsin (AAT) for the treatment of inflammatory diseases, virus infections and rare diseases. The first product candidate is a novel AAT formulation for inhalation to treat emerging inflammatory diseases of the lung and respiratory virus infections.

Aix Scientifics is a Contract Research Organisation that specializes in planning, implementing, and evaluating clinical research for pharmaceutical products and medical devices.

Anbio Biotechnology (Anbio) is a leading global medical device company with a focus on in vitrodiagnostics. Our goal is to revolutionize the diagnostics market by personalizing and decentralizingcurrent diagnostic solutions, enabling rapid diagnosis and improving patient prognosis. Weachieve this by offering cutting-edge laboratory, wellness, at-home, and point-of-care (POCT) invitro diagnostic (lVD) solutions that are rapid, accessible, and affordable on a global scale. Since its establishment, Anbio has been committed to delivering the most advanced diagnosticsolutions while ensuring cost-effectiveness for our customers. Our extensive capabilities inresearch and development, manufacturing, and global product distribution logistics allowing us tocontinuously focus on cost reduction while offering a wide range of mature laboratory diagnosticsand point-of-care technology (POCT) products. Our product range spans across cancer, cardio.vascular conditions, pharmacogenomics, hormones, infectious diseases, inflammation, and drugsof abuse tests.

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Our products and services are designed to benefit people and improve their quality of life. At the same time, we aim to create value through innovation, growth and high earning power. Our products help address some of today’s biggest challenges, including global population growth, an aging society and the need to make efficient – and, wherever possible, sustainable – use of natural resources. In line with our mission “Bayer: Science For A Better Life,” we aim to improve people’s quality of life by preventing, alleviating or curing diseases. We also help provide an adequate supply of high-quality food, feed and renewable plant-based raw materials. For these endeavors, we focus on developing and successfully commercializing innovative products and solutions based on scientific knowledge.

B. Braun is one of the world's leading medical technology companies. With over 65,000 employees, the family-owned company is a true partner, developing smart solutions and setting standards to drive advancements in health care. In 2022, the B. Braun Group generated sales of € 8.5 billion. You want to protect and improve the health of people around the world? Then you need a work environment that makes it easy for you to give your best. We bring together people in a collaborative culture. We encourage them to be open-minded, learn from each other and create new solutions together. In a time of rapid technological change, we constantly strive to enhance the solutions we provide. This is why we promote innovative ways of thinking and accountability. Imprint: https://www.bbraun.com/en/imprint.html Privacy Policy: https://www.bbraun.com/en/privacy-policy.html

BELANO - The Microbiome Company Die Erforschung des menschlichen Mikrobioms hat in den letzten Jahren zu wegweisenden Erkenntnissen geführt. Das Verständnis der Wechselwirkung zwischen Bakterienwelt um uns herum und unseren Körperfunktionen führt zu innovativen Therapieansätzen. Aus dieser Forschung sind bei BELANO mikrobiotische Wirkstoffe entstanden, die in Produkten in den Bereichen Derma & Kosmetik, Hals & Rachen, Mund & Magen und Wundversorgung & Hygiene eingesetzt werden.

Bosch Healthcare Solutions (BHCS) is a wholly owned subsidiary of Robert Bosch GmbH and was founded in 2015. We create innovative diagnostic solutions to improve people's quality of life and global healthcare. BHCS unites the innovative mindset of a young company with the leading expertise and quality claim of the Bosch brand. We tailor our products and services to the needs of our customers in order to continuously optimize the user experience. Our vision is to make healthcare routines a little better and easier every day. This motivates our interdisciplinary teams to pursue excellence. Corporate information: bosch-healthcare.com/en/corporate-information/ Privacy Policy: bosch-healthcare.com/en/data-privacy/

Capnopharm develops aerosol-based chemotherapies and immunotherapies for peritoneal and pleural cancer patients. Our science relies on a growing body of evidence around PIPAC™ (Pressurized Intraperitoneal Aerosol Chemotherapy), a minimally invasive aerosol drug delivery system. PIPAC™ provides numerous avenues for research and development in oncology – from re-formulation of existing chemotherapy drugs to next-generation drugs involving Nanoparticles, DNA, mRNA or Immunotherapeutics. Together with our pharmaceutical clients, we explore drug-device synergies which could shape the future of cancer care. In doing so, we are devoted to our mission of improving the health and well-being of cancer patients around the world, for the best possible quality of life.

CRELUX, part of WuXi AppTec’s Research Service Division, is a global provider of structure based drug discovery solutions. We have been delivering customized and integrated services in drug discovery, X-ray crystallography, protein supply, biophysical analysis and fragment screening, to support small and large molecule, as well as biopharmaceutical drug discovery, for more than a decade. Our mission is to enable our clients to perform their work faster, more efficiently and more successfully. Integrating the comprehensive portfolio of services offered by our parent company WuXi AppTec, CRELUX offers a unique opportunity for our collaborators to accelerate discovery activities. Imprint: CRELUX GmbH Am KIopferspitz 19a 82152 Martinsried Germany www.crelux.com crelux_info@wuxiapptec.com VAT: DE242220245 Amtsgericht München HRB 165552 Managing Directors: Dr. Alex Satz, Dr. Thomas Meins

DeepEn offers hair-thin endomicroscopy solutions capable of subcellular resolution and high-speed observations within hard-to-access body regions. Our minimally invasive devices are used in research and diagnostics, helping to advance our understanding of diseases and microscopic processes deep inside sensitive tissues in real time. DeepEn was founded in 2024 as a spinoff from the Department for Holographic Endoscopy, led by Prof Dr Tomas Cizmar at Leibniz Institute of Photonic Technology in Jena, Germany. Our Managing Director is Dr Sergey Turtaev.

Awarded for "most innovative German startup" from German business magazine Bilanz, DiaMonTech has developed a medical device that non-invasively measures your blood glucose without finger pricking, a drop of blood, or a test strip. Simply relax your fingertip on the sensor, wait 5 to 15 seconds, and your blood glucose level will be displayed. Our patented technology works with an invisible infrared light beam that looks into your skin and counts glucose molecules. Diabetes is a global challenge. More than 400 million people worldwide suffer from the disease. Our goal is to make checking your blood glucose level as easy as unlocking your phone. You will be able to get measurements throughout the day without pain or extra costs. Diabetologists suggest that more frequent blood glucose measurements can lead to better overall diabetes management and less diabetes-related illnesses. Until there's a cure for diabetes, DiaMonTech can make living with it much easier.

Heraeus is a family-owned global technology group headquartered in Hanau, Germany. The company's roots go back to a family pharmacy started in 1660. With its expertise and resources, Heraeus has been making meaningful contributions over generations and is committed to do so in the future. Today, the group bundles diverse activities in four Business Platforms: Metals and Recycling, Healthcare, Semiconductor and Electronics, as well as Industrials. Customers benefit from innovative technologies and solutions based on broad materials knowledge and technological leadership. In the 2023 financial year, the group generated revenues of €25.6 billion (US$27.7 billion*) with approximately 16,400 employees in 40 countries. Heraeus is one of the top 10 familyowned companies in Germany.

InspireMD is a commercial-stage medical device company with proprietary and innovative stent designs with integrated embolic prevention systems (EPS) designed for delivering neurovascular protection and stroke prevention. InspireMD is dedicated to the development of advanced technologies and seeks to utilize its proprietary MicroNet™ technology to make its products the industry standard for treatment of carotid artery disease by providing outstanding acute results and durable stroke free long-term outcomes through a proprietary stent platform, CGuard™ EPS. CGuard brings to the world the only carotid stent platform with patented MicroNet™ mesh technology designed to reduce stroke during and after CAS. InspireMD (NSPR) is traded on NASDQ Capital Markets.

Mainz Biomed (NASDAQ: MYNZ) was founded in Germany and is becoming a leading molecular genetic diagnostics company developing market-ready molecular genetic diagnostic solutions. The company's goal is to place effective solutions in the hands of those who need them, with a focus on medical revolutions in diagnostic technology. Mainz Biomed offers genetic and genomic tests that identify the unique genetic profile of individual patients, as well as in-vitro diagnostic tests for the early detection of cancer in the United States.

neoplas med GmbH was founded in 2009 as a spin-off of the Leibniz Institute for Plasma Science and Technology e. V. (INP) in Greifswald, Germany. Based on the INP research into plasma medicine, the emerging company develops innovative products for medical applications. The first product developed on this basis is the CE-marked kINPen® MED atmospheric pressure plasmajet, the first internationally approved and marketed plasma jet for the treatment of chronic wounds and pathogen-induced skin disorders. It is the result of a long-lasting cooperation with the INP institute, the university hospital of Greifswald, Germany, the Charité hospital of Berlin, Germany, and various industrial partners.

Noah Labs develops AI-based software solutions for medical care and research to facilitate diagnosis, manage conditions, and guide intervention.

ORGENTEC Diagnostika based in Mainz, Germany, is a diagnostics company, focused on automation of laboratory tests in the fields of autoimmunity and infectious diseases. Enzyme linked immunosorbent assays (ELISA), immunoblots and immunofluorescence assays are "made in Germany" - with research and development, production and distribution from Mainz to over 100 countries.

Penumbra is a medical devices company that specializes in neurovascular products and healthcare technology.

At SOMATEX®, we are dedicated to improving healthcare by providing high quality solutions every day. For more than 25 years, we have brought new products and technologies to the world, especially in the fields of breast care, soft tissue and bone marrow biopsy, pulmonary interventions, fetal therapy, assisted reproduction and radiation protection. Thanks to exceptional innovations, we have set new standards in women's health. We are committed to meet the needs of patients, clinicians and practitioners to enable better diagnostics and therapies and improve the standard of care. Today, SOMATEX® products are used around the world in university clinics, hospitals, breast centers and medical practices to continuously improve the quality of patients' life. Our growth is driven by the strength of our research and development capability, highly qualified employees that share our vision and values, and our strong network of partners. For more information visit our website: www.somatex.com

Founded in 2000, TauroPharm GmbH is a German company specialising in medical devices with antimicrobial efficacy. As TauroLock™ solutions have been recommended in expert guidelines, we continue to expand our global network.  Our mission  TauroPharm aims to make the application of vascular access devices (VAD) easier and safer. We are developing more effective ways to prevent catheter-associated complications – ranging from blood clotting to fatal infections. Improving the patient's quality of life remains our number-one priority.  Our products  We have created a range of lock solutions suitable for implanted central-venous catheters (CVC) and port systems. These products contain several ingredients to prevent catheter occlusion and catheter-related infections. Today, TauroLock™ solutions are recommended in interdisciplinary guidelines on a national and international scale. These include the ESPEN (European Society for Clinical Nutrition and Metabolism), GAVeCeLT (Italian association for long-term central-venous access devices), SFNCM (French Society of Clinical Nutrition and Metabolism), and DGfN (German Society of Nephrology). All TauroLock™ products have been investigated in clinical trials and are certified by regulatory bodies.  Our sales network  To distribute our products, we collaborate with international partners who provide support and advice to customers in their respective countries. Our correspondents have been carefully selected and hold trust-based partnerships with healthcare professionals in nephrology, oncology, gastroenterology, intensive and palliative medicine, and home care.   Our educational programmes  TauroPharm offers special training in all countries where TauroLock™ products are sold and implemented. These programmes help distributors familiarise themselves with our lock solutions and their application. Privacy policy: https://www.wonderlink.de/@tauropharm

We turn active ingredients into medicine. As one of the leading pharmaceutical service providers for the aseptic manufacture of injectable medicines, we are a global player – and a family business. Together with our 6,000 employees, we help improve the lives of people around the world. We combine tradition and innovation in a job that has meaning. Ravensburg is where our roots are. We make a significant contribution to reliably supplying patients with medicines from our state-of-the-art production sites in Europe and the United States. We work hand in hand with pharmaceutical and biotechnology companies of all sizes, accompanying them on their journey to help those who are affected with their treatment of cancer, multiple sclerosis, and other diseases – from active ingredient development all the way to its delivery in people. With success comes responsibility. Teamwork, openness, and commitment: These qualities are important to us. At Vetter, we are sustainably helping to shape the future. We fully support personal and professional development – to build a strong team in which everyone can develop their skills, and in which every contribution counts. And for those who rely on us. Find out more about our company at www.vetter-pharma.com/ Privacy Notice: https://www.vetter-pharma.com/en/privacy-notice Imprint: https://www.vetter-pharma.com/en/imprint